Target intelligence / Profile preview

Multidrug resistance protein 1 and Multidrug resistance-associated protein 1 (P-gp and MRP1)

Target
P-gp and MRP1
Molecular classification
Transporter, ATP-binding cassette (ABC) transporter
01

Overview

P-glycoprotein (P-gp), encoded by the ABCB1 gene, and Multidrug resistance-associated protein 1 (MRP1), encoded by the ABCC1 gene, are integral membrane proteins belonging to the ATP-binding cassette (ABC) transporter superfamily (UniProt P08183, P33527). These transporters utilize the energy of ATP hydrolysis to export a broad spectrum of chemically unrelated compounds, including various chemotherapeutic agents, from the cytoplasm to the extracellular space (PubMed: 25048911). Their primary biological role is to protect cells from xenobiotic toxicity and maintain physiological barriers, such as the blood-brain and blood-placental barriers (NIH: StatPearls). In clinical oncology, the overexpression of P-gp and MRP1 is a major driver of multidrug resistance (MDR), leading to the failure of chemotherapy in various cancers by preventing drugs from reaching therapeutic concentrations within tumor cells (PubMed: 30553482). While several generations of inhibitors, such as Tariquidar and Elacridar, have been developed to reverse MDR, their clinical utility has been limited by significant safety concerns, including the disruption of normal tissue protection and complex drug-drug interactions (PubMed: 23633442).

Other names
P-glycoproteinMDR1ABCB1ABCC1ATP-binding cassette sub-family B member 1ATP-binding cassette sub-family C member 1Multidrug resistance-associated protein 1
02

Mechanism of action

ATP-dependent efflux of substrate molecules across the cell membrane against a concentration gradient, reducing intracellular drug accumulation.

03

Biological functions

Xenobiotic transportDrug effluxHomeostasisProtection of physiological barriersLipid transport
04

Disease associations

CancerMultidrug resistanceEpilepsyAlzheimer's diseaseInfection
05

Safety considerations

Increased systemic toxicity of co-administered drugsAltered blood-brain barrier integritySignificant drug-drug interactions (DDIs)Potential for neurotoxicity due to increased brain penetration of toxins
06

Interacting drugs

Verapamil

10 more in the full profile.

07

Biomarkers

ABCB1 mRNA expressionABCC1 mRNA expressionRhodamine 123 efflux capacityCalcein-AM efflux capacityP-gp protein levels (IHC)

Beyond the preview

Go deeper on Multidrug resistance protein 1 and Multidrug resistance-associated protein 1 (P-gp and MRP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multidrug resistance protein 1 and Multidrug resistance-associated protein 1 (P-gp and MRP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call